Proceedings from a CME symposium held at the 2019 ASCO Annual
Meeting. Featuring perspectives from Dr D Ross Camidge, Dr Stephen
V Liu, Prof Solange Peters, Dr Gregory J Riely and Dr David R
Spigel.
Introduction (00:00)
Optimal Therapeutic Approaches for Patients with Metastatic
Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations — Dr
Riely (3:24)
Management of NSCLC with ALK Rearrangements or Other Targetable
Abnormalities — Dr Camidge (30:37)
Current and Emerging Paradigms in the Treatment of Small Cell
Lung Cancer (SCLC) — Dr Liu (56:45)
Integration of Immune Checkpoint Inhibition into the Management
of Locally Advanced NSCLC — Dr Spigel (1:10:55)
Available Data with and Current Clinical Role of
Anti-PD-1/PD-L1 Antibodies Alone or in Combination with Other
Systemic Therapies for Patients with Metastatic NSCLC — Prof Peters
(1:34:06)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.